title: Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner.
abstract: Addicts repeatedly relapse to drug seeking even after years of abstinence, and this behavior is frequently induced by the recall of memories of the rewarding effects of the drug. Established memories, including those induced by drugs of abuse, can become transiently fragile if reactivated, and during this labile phase, known as reconsolidation, can be persistently disrupted. Here we show that, in rats, a morphine-induced place preference (mCPP) memory is linked to context-dependent withdrawal as disrupting the reconsolidation of the memory leads to a significant reduction of withdrawal evoked in the same context. Moreover, the hippocampus plays a critical role in linking the place preference memory with the context-conditioned withdrawal, as disrupting hippocampal protein synthesis and cAMP-dependent-protein kinase A after the reactivation of mCPP significantly weakens the withdrawal. Hence, targeting memories induced by drugs may represent an important strategy for attenuating context-conditioned withdrawal and therefore subsequent relapse in opiate addicts.
authors.affiliation: Departments of Neuroscience, Mount Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Taubenfeld
authors.forename: Elizaveta V
authors.initials: EV
authors.lastname: Muravieva
authors.forename: Ana
authors.initials: A
authors.lastname: Garcia-Osta
authors.forename: Cristina M
authors.initials: CM
authors.lastname: Alberini
mesh_terms: D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects / Q000502:physiology; D003213:Conditioning, Psychological / Q000502:physiology; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D003513:Cycloheximide / Q000008:administration & dosage; D006624:Hippocampus / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D008297:Male; D008568:Memory / Q000187:drug effects / Q000502:physiology; D008569:Memory Disorders / Q000503:physiopathology* / Q000523:psychology; D009020:Morphine / Q000008:administration & dosage; D009021:Morphine Dependence / Q000503:physiopathology* / Q000523:psychology; D009042:Motivation / Q000187:drug effects / Q000502:physiology*; D009294:Narcotics / Q000008:administration & dosage; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D020318:Rats, Long-Evans; D013037:Spatial Behavior / Q000187:drug effects / Q000502:physiology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology* / Q000523:psychology
chemical_list: D009294:Narcotics; D011500:Protein Synthesis Inhibitors; D009020:Morphine; D003513:Cycloheximide; D017868:Cyclic AMP-Dependent Protein Kinases